Correlation Between Mangoceuticals, Common and CPSI Old
Can any of the company-specific risk be diversified away by investing in both Mangoceuticals, Common and CPSI Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangoceuticals, Common and CPSI Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mangoceuticals, Common Stock and CPSI Old, you can compare the effects of market volatilities on Mangoceuticals, Common and CPSI Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangoceuticals, Common with a short position of CPSI Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangoceuticals, Common and CPSI Old.
Diversification Opportunities for Mangoceuticals, Common and CPSI Old
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mangoceuticals, and CPSI is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Mangoceuticals, Common Stock and CPSI Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CPSI Old and Mangoceuticals, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangoceuticals, Common Stock are associated (or correlated) with CPSI Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CPSI Old has no effect on the direction of Mangoceuticals, Common i.e., Mangoceuticals, Common and CPSI Old go up and down completely randomly.
Pair Corralation between Mangoceuticals, Common and CPSI Old
If you would invest 2,533 in CPSI Old on September 12, 2024 and sell it today you would earn a total of 0.00 from holding CPSI Old or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Mangoceuticals, Common Stock vs. CPSI Old
Performance |
Timeline |
Mangoceuticals, Common |
CPSI Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Mangoceuticals, Common and CPSI Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mangoceuticals, Common and CPSI Old
The main advantage of trading using opposite Mangoceuticals, Common and CPSI Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangoceuticals, Common position performs unexpectedly, CPSI Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CPSI Old will offset losses from the drop in CPSI Old's long position.Mangoceuticals, Common vs. FOXO Technologies | Mangoceuticals, Common vs. Healthcare Triangle | Mangoceuticals, Common vs. Bullfrog AI Holdings, | Mangoceuticals, Common vs. EUDA Health Holdings |
CPSI Old vs. National Research Corp | CPSI Old vs. Forian Inc | CPSI Old vs. HealthEquity | CPSI Old vs. Health Catalyst |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
CEOs Directory Screen CEOs from public companies around the world |